Busulfan Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Busulfan Injection (injection) from Mylan Institutional, A Viatris Company with status No longer listed by FDA. The shortage was first posted on Oct 24, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Mylan Institutional, A Viatris Company
- Package NDC
- 67457-893-08
- Dosage Form
- Injection
- Presentation
- Busulfan, Injection, 6 mg/1 mL (NDC 67457-893-08)
- Initial Posting
- Oct 24, 2025